Article Data

  • Views 1058
  • Dowloads 140

Reviews

Open Access

Malignant primary peritoneal mesothelioma: report of two cases and review of literature

  • I˙. Dunder1
  • C. Baykal2,*,
  • I˙. Turkmen3
  • N. Bas¸süllü3
  • G.B. Dog˘usoy4
  • G. Demir4

1Department of Obstetrics and Gynecology, Bilim University School of Medicine, Turkey

2Department of Obstetrics and Gynecology, Florence Nightingale Kadikoy Hospital, Turkey

3Department of Pathology, Bilim University School of Medicine, Turkey

4Department of Medical Oncology, Bilim University School of Medicine, Istanbul, Turkey

DOI: 10.12892/ejgo201205549 Vol.33,Issue 5,September 2012 pp.549-551

Published: 10 September 2012

*Corresponding Author(s): C. Baykal E-mail: cem.baykal@ttmail.com

Abstract

Introduction: Malignant primary peritoneal mesothelioma is a rare and highly aggressive tumor. This tumor can be misdiagnosed as ovarian carcinoma. Case: Two cases of malignant primary peritoneal mesothelioma that were misdiagnosed as ovarian carcinoma were operated in our instutition. Patients were 74 and 45 years-old at admittance. Conclusion: Malignant primary peritoneal mesothelioma is being a problem for gynecologic oncologists because of the close similarity with epithelial ovarian cancer. Diagnosis and treatment of these patients are still under debate.

Keywords

Peritoneal mesothelioma; Diagnosis; Epithelial ovarian cancer

Cite and Share

I˙. Dunder,C. Baykal,I˙. Turkmen,N. Bas¸süllü,G.B. Dog˘usoy,G. Demir. Malignant primary peritoneal mesothelioma: report of two cases and review of literature. European Journal of Gynaecological Oncology. 2012. 33(5);549-551.

References

[1] Miller J., Wynn W.H.: “A malignant tumour arising from the endothelium of the peritoneum and producing a mucoid ascitic fluid”. J. Pathol. Bacteriol., 2005, 12, 267.

[2] Antman K., Shemin R., Ryan L., Klegar K., Osteen R., Herman T., Lederman G., Corson J.: “Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965-1985”. J. Clin. Oncol., 1988, 6, 147.

[3] Sridhar K.S., Doria R., Raub W.A. Jr., Thurer R.J., Saldana M.: “New strategies are needed in diffuse malignant mesothelioma”. Cancer, 1992, 70, 2969.

[4] Yates D.H., Corrin B., Stidolph P.N., Browne K.: “Malignant mesothelioma in south east England: clinicopathological experience of 272 cases”. Thorax, 1997, 52, 507.

[5] Markaki S., Protopapas A., Milingos S., Lazaris D., Antsaklis A., Michalas S.: “Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study”. Gynecol. Oncol., 2005, 96, 860.

[6] Ordóñez N.G.: “Immunohistochemical diagnosis of epithelioid me - sothelioma: an update”. Arch. Pathol. Lab. Med., 2005, 129, 1407.

[7] Baykal C., Ariog˘lu P., Gultekin M., Usubutun A., Ficicioglu C., Ayhan A.: “Well differentiated mesothelioma complicating endometrial carcinoma; a case report”. Eur. J. Gynaecol. Oncol., 2006, 27, 200.

[8] de Pangher Manzini V.: “Malignant peritoneal mesothelioma”. Tumori, 2005, 91, 1.

[9] Su P.Y., Chen Y.Y., Yen H.H.: “Unusual abdominal tumor: peritoneal mesothelioma”. Clin. Gastroenterol. Hepatol., 2011, 9, 68.

Submission Turnaround Time

Top